NARAVELA 250 micrograms/35 micrograms, tablet 63 tablets
Active ingredients: Norgestimate, Ethinylestradiol
Commercialized according to BDPMDispensing in France: Prescription only
Tablet63 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- NARAVELA 250 microgrammes/35 microgrammes, comprimé
- Pharmaceutical form
- comprimé
- Route of administration
- orale
- Presentation description
- 3 plaquettes PVC PVDC aluminium de 21 comprimés
- Marketing authorisation holder
- EXELTIS SANTE
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 17 Jun 2020
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65464991CIP73016967CIP133400930169674Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| ÉTHINYLESTRADIOLcomprimé | 35 microgrammes · un comprimé | SA |
| NORGESTIMATEcomprimé | 250 microgrammes · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.